ONLINE DOCTOR CONSULTATION - BOOK AN APPOINTMENT

Nov 29, 2016

news on november 2016

In a bid to counter this allegation that Ayurvedic are inefficacious, we have looped in scientific institutes such as Indian Institute of Technology (IIT) Bombay and AIIMS," said Anil Kumar Ganeriwala, Joint Secretary,
AYUSH Ministry told DNA.
While the Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) is launching “Mission Madhumeha through Ayurveda” on Friday, modern medicine doctors continue to be at loggerheads over efficacy of the alternative system of medicine for treatment of diabetes.

A heated debate over the issue has been continuing in recent editions of 'The Lancet' via posts giving alternative therapies a thumbs down.  
    
Unabated doubts raised by diabetes experts over Ayurvedic drugs have also moved the AYUSH ministry to get concrete proof to their claims. “In a bid to counter this allegation that Ayurvedic are inefficacious, we have looped in scientific institutes such as Indian Institute of Technology (IIT) Bombay and All India Institute of Medical Sciences (AIIMS). They are researching to establish efficacy of Ayurvedic drugs not only for diabetes but for other diseases also,” Anil Kumar Ganeriwala, Joint Secretary, AYUSH Ministry told DNA.

Since March, there has been a brisk exchange of opinions over the issue in “The Lancet” with a latest correspondence on Wednesday. The first post titled 'Maximum Hype, Minimum Science' was published in the Medical Journal in March 2016, by a noted endocrinologist Dr Anoop Misra, who claimed there is insufficient scientific evidence to recommend Ayurvedic drugs in routine clinical practice.

In reply to the post, Ayurvedic experts Rajiv Vasudevan and Zankhana Buch, stated, “Regarding the scarcity of studies of Ayurvedic treatments mentioned by Misra and colleagues, it is important to keep in mind that classic Ayurvedic medicines are usually polyherbal formulations. The combined effect of the phytochemical constituents of various herbs is responsible for therapeutic efficacy, rather than the actions of a single active ingredient.
“Standard double-blind randomised controlled trials are not frequently used for Ayurvedic treatments because the multi-faceted approach to diabetes management is not amenable totrials,” they stated.
               

0 comments:

Post a Comment

Popular Posts

ayurvedic immunity booster